Novartis Japan unit faces business suspension order

Photo taken June 12, 2014, shows the building in Tokyo's Minato Ward housing a Japanese unit of Swiss pharmaceutical maker Novartis AG. The health ministry has decided to order a business suspension of around 15 days for the Tokyo-based company for not reporting serious side effects of its drugs, sources close to the matter said on Feb. 2, 2015. (Kyodo) ==Kyodo

Sample
PDF Preview

Product Code
ILEA000046027

Registered date
2015/2/03 11:58:43

Credit
Kyodo / Kyodo News Images

Media source

Media size
2623 × 3968 pixel

Resolution
240 dpi

Deployment size
697.44(KB)*

Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos

Toshiba could incur 700 bil. yen loss, asks state-owned bank for aid

File photo taken Jan. 7, 2017, shows a sign for Toshiba Corp. on the rooftop of a building in Tokyo. The Japanese electronics manufacturer has sought financial assistance from the state-owned Development Bank of Japan as it expects an asset impairment loss of up to 700 billion yen ($6.17 billion) from its U.S. nuclear business, sources close to the matter said Jan. 19. (Kyodo) ==Kyodo

Takeda in talks to take over stomach drug arm of Canada's Valeant

File photo taken in October 2010 shows the Tokyo headquarters of Takeda Pharmaceutical Co. The Japanese company is in talks to take over the stomach drug business of Canada's Valeant Pharmaceuticals International Inc., sources familiar with the matter said on Nov. 2, 2016. (Kyodo) ==Kyodo

Toshiba to incur around 500 bil. yen net loss in FY 2015

File photo taken in July 2015 shows a building which houses Toshiba Corp.'s headquarters in Tokyo. The electronics maker expects a record group net loss of around 500 billion yen ($4.13 billion) for the business year ending in March 2016, as it makes greater efforts to streamline operations following its profit-padding scandal, a company source said on Dec. 19, 2015. (Kyodo) ==Kyodo